Skip to main content
Top
Published in: Diabetology & Metabolic Syndrome 1/2012

Open Access 01-12-2012 | Research

Metabolic syndrome in central Brazil: prevalence and correlates in the adult population

Authors: Eliane Said Dutra, Kênia MaraBaiocchi de Carvalho, Édina Miyazaki, Edgar Merchán- Hamann, Marina Kiyomi Ito

Published in: Diabetology & Metabolic Syndrome | Issue 1/2012

Login to get access

Abstract

Background

The prevalence of metabolic syndrome (MetS) has increased in developing countries in recent decades. This syndrome, a clustering of metabolic abnormalities, has been correlated to various socioeconomic and behavioral variables. We investigated the prevalence and prevalence ratios (PR) of MetS and related factors in an adult population of the Federal District (FD) of Brazil, which is located in the central region of the country.

Methods

A cross-sectional, population-based study conducted in 2007, with 2130 adults (aged 18 years or older) in the FD of Brazil. Metabolic syndrome was defined according to the recently harmonized criteria. The prevalence of MetS and PR were estimated for each sex according to the diagnostic components and the overall contribution of the selected correlates.

Results

The overall prevalence of MetS was 32.0% (95%CI: 28.9–35.2), with no gender difference. The single component with the greatest contribution to the diagnosis of MetS was hypertension in men (PR 5.10, 95%CI: 3.17–8.22) and high waist circumference in women (PR 5.02, 95%CI: 3.77–6.69). The prevalence of MetS increased significantly and progressively with age and excess weight. In women, higher education was protective against MetS (PR 0.66, 95%CI: 0.49–0.89) compared to 8 or less years of education. There was no association between the prevalence of MetS and behavioral variables studied.

Conclusions

This study provides comprehensive and alarming data about the prevalence of MetS among the adult population of Brazil’s FD. The results suggest that reducing education inequalities may be an important public policy goal to improve health outcomes, especially among women.
Literature
1.
go back to reference Gaziano TA, Bitton A, Anand S, Abrahams-Gessel S, Murphy A: Growing epidemic of coronary heart disease in low- and middle-income countries. Curr Probl Cardiol. 2010, 35: 72-115. 10.1016/j.cpcardiol.2009.10.002.PubMedCentralCrossRefPubMed Gaziano TA, Bitton A, Anand S, Abrahams-Gessel S, Murphy A: Growing epidemic of coronary heart disease in low- and middle-income countries. Curr Probl Cardiol. 2010, 35: 72-115. 10.1016/j.cpcardiol.2009.10.002.PubMedCentralCrossRefPubMed
2.
go back to reference Gersh BJ, Sliwa K, Mayosi BM, Yusuf S: Novel therapeutic concepts: the epidemic of cardiovascular disease in the developing world: global implications. Eur Heart J. 2010, 31: 642-648. 10.1093/eurheartj/ehq030.CrossRefPubMed Gersh BJ, Sliwa K, Mayosi BM, Yusuf S: Novel therapeutic concepts: the epidemic of cardiovascular disease in the developing world: global implications. Eur Heart J. 2010, 31: 642-648. 10.1093/eurheartj/ehq030.CrossRefPubMed
3.
go back to reference Alberti K, Eckel R, Grundy S, Zimmet P, Cleeman J, Donato K, Fruchart J, James W, Loria C, Smith S: Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009, 120: 1640-1645. 10.1161/CIRCULATIONAHA.109.192644.CrossRefPubMed Alberti K, Eckel R, Grundy S, Zimmet P, Cleeman J, Donato K, Fruchart J, James W, Loria C, Smith S: Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009, 120: 1640-1645. 10.1161/CIRCULATIONAHA.109.192644.CrossRefPubMed
4.
go back to reference Ford ES, Li C, Sattar N: Metabolic syndrome and incident diabetes: current state of the evidence. Diabetes Care. 2008, 31: 1898-1904. 10.2337/dc08-0423.PubMedCentralCrossRefPubMed Ford ES, Li C, Sattar N: Metabolic syndrome and incident diabetes: current state of the evidence. Diabetes Care. 2008, 31: 1898-1904. 10.2337/dc08-0423.PubMedCentralCrossRefPubMed
5.
go back to reference Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, Somers VK, Montori VM: Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol. 2007, 49: 403-414. 10.1016/j.jacc.2006.09.032.CrossRefPubMed Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, Somers VK, Montori VM: Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol. 2007, 49: 403-414. 10.1016/j.jacc.2006.09.032.CrossRefPubMed
6.
go back to reference Wilson PW, D’Agostino RB, Parise H, Sullivan L, Meigs JB: Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation. 2005, 112: 3066-3072. 10.1161/CIRCULATIONAHA.105.539528.CrossRefPubMed Wilson PW, D’Agostino RB, Parise H, Sullivan L, Meigs JB: Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation. 2005, 112: 3066-3072. 10.1161/CIRCULATIONAHA.105.539528.CrossRefPubMed
7.
go back to reference Bayturan O, Tuzcu EM, Lavoie A, Hu T, Wolski K, Schoenhagen P, Kapadia S, Nissen SE, Nicholls SJ: The metabolic syndrome, its component risk factors, and progression of coronary atherosclerosis. Arch Intern Med. 2010, 170: 478-484. 10.1001/archinternmed.2009.551.CrossRefPubMed Bayturan O, Tuzcu EM, Lavoie A, Hu T, Wolski K, Schoenhagen P, Kapadia S, Nissen SE, Nicholls SJ: The metabolic syndrome, its component risk factors, and progression of coronary atherosclerosis. Arch Intern Med. 2010, 170: 478-484. 10.1001/archinternmed.2009.551.CrossRefPubMed
8.
go back to reference Mente A, Yusuf S, Islam S, McQueen MJ, Tanomsup S, Onen CL, Rangarajan S, Gerstein HC, Anand SS: Metabolic syndrome and risk of acute myocardial infarction a case–control study of 26,903 subjects from 52 countries. J Am Coll Cardiol. 2010, 55: 2390-2398. 10.1016/j.jacc.2009.12.053.CrossRefPubMed Mente A, Yusuf S, Islam S, McQueen MJ, Tanomsup S, Onen CL, Rangarajan S, Gerstein HC, Anand SS: Metabolic syndrome and risk of acute myocardial infarction a case–control study of 26,903 subjects from 52 countries. J Am Coll Cardiol. 2010, 55: 2390-2398. 10.1016/j.jacc.2009.12.053.CrossRefPubMed
9.
go back to reference Simmons RK, Alberti KG, Gale EA, Colagiuri S, Tuomilehto J, Qiao Q, Ramachandran A, Tajima N, Brajkovich Mirchov I, Ben-Nakhi A, Reaven G, Hama Sambo B, Mendis S, Roglic G: The metabolic syndrome: useful concept or clinical tool? Report of a WHO Expert Consultation. Diabetologia. 2010, 53: 600-605. 10.1007/s00125-009-1620-4.CrossRefPubMed Simmons RK, Alberti KG, Gale EA, Colagiuri S, Tuomilehto J, Qiao Q, Ramachandran A, Tajima N, Brajkovich Mirchov I, Ben-Nakhi A, Reaven G, Hama Sambo B, Mendis S, Roglic G: The metabolic syndrome: useful concept or clinical tool? Report of a WHO Expert Consultation. Diabetologia. 2010, 53: 600-605. 10.1007/s00125-009-1620-4.CrossRefPubMed
10.
go back to reference Cameron A: The metabolic syndrome: validity and utility of clinical definitions for cardiovascular disease and diabetes risk prediction. Maturitas. 2010, 65: 117-121. 10.1016/j.maturitas.2009.11.026.CrossRefPubMed Cameron A: The metabolic syndrome: validity and utility of clinical definitions for cardiovascular disease and diabetes risk prediction. Maturitas. 2010, 65: 117-121. 10.1016/j.maturitas.2009.11.026.CrossRefPubMed
11.
go back to reference Misra A, Khurana L: Obesity and the metabolic syndrome in developing countries. J Clin Endocrinol Metab. 2008, 93 (Suppl 1): 9-30.CrossRef Misra A, Khurana L: Obesity and the metabolic syndrome in developing countries. J Clin Endocrinol Metab. 2008, 93 (Suppl 1): 9-30.CrossRef
12.
go back to reference Batsis JA, Nieto-Martinez RE, Lopez-Jimenez F: Metabolic syndrome: from global epidemiology to individualized medicine. Clin Pharmacol Ther. 2007, 82: 509-524. 10.1038/sj.clpt.6100355.CrossRefPubMed Batsis JA, Nieto-Martinez RE, Lopez-Jimenez F: Metabolic syndrome: from global epidemiology to individualized medicine. Clin Pharmacol Ther. 2007, 82: 509-524. 10.1038/sj.clpt.6100355.CrossRefPubMed
13.
go back to reference Cornier MA, Dabelea D, Hernandez TL, Lindstrom RC, Steig AJ, Stob NR, Van Pelt RE, Wang H, Eckel RH: The metabolic syndrome. Endocr Rev. 2008, 29: 777-822. 10.1210/er.2008-0024.CrossRefPubMed Cornier MA, Dabelea D, Hernandez TL, Lindstrom RC, Steig AJ, Stob NR, Van Pelt RE, Wang H, Eckel RH: The metabolic syndrome. Endocr Rev. 2008, 29: 777-822. 10.1210/er.2008-0024.CrossRefPubMed
14.
go back to reference Executive Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults: Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001, 285: 2486-2497. 10.1001/jama.285.19.2486.CrossRef Executive Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults: Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001, 285: 2486-2497. 10.1001/jama.285.19.2486.CrossRef
15.
go back to reference Escobedo J, Schargrodsky H, Champagne B, Silva H, Boissonnet CP, Vinueza R, Torres M, Hernandez R, Wilson E: Prevalence of the metabolic syndrome in Latin America and its association with sub-clinical carotid atherosclerosis: the CARMELA cross sectional study. Cardiovasc Diabetol. 2009, 26: 52-60.CrossRef Escobedo J, Schargrodsky H, Champagne B, Silva H, Boissonnet CP, Vinueza R, Torres M, Hernandez R, Wilson E: Prevalence of the metabolic syndrome in Latin America and its association with sub-clinical carotid atherosclerosis: the CARMELA cross sectional study. Cardiovasc Diabetol. 2009, 26: 52-60.CrossRef
16.
go back to reference Finucane MM, Stevens GA, Cowan MJ, Danaei G, Lin JK, Paciorek CJ, Singh GM, Gutierrez HR, Lu Y, Bahalim AN, Farzadfar F, Riley LM, Ezzati M: National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9· 1 million participants. Lancet. 2011, 377: 557-567. 10.1016/S0140-6736(10)62037-5.PubMedCentralCrossRefPubMed Finucane MM, Stevens GA, Cowan MJ, Danaei G, Lin JK, Paciorek CJ, Singh GM, Gutierrez HR, Lu Y, Bahalim AN, Farzadfar F, Riley LM, Ezzati M: National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9· 1 million participants. Lancet. 2011, 377: 557-567. 10.1016/S0140-6736(10)62037-5.PubMedCentralCrossRefPubMed
17.
go back to reference Schmidt MI, Duncan BB, Azevedo e Silva G, Menezes AM, Monteiro CA, Barreto SM, Chor D, Menezes PR: Chronic non-communicable diseases in Brazil: burden and current challenges. Lancet. 2011, 377: 1949-1961. 10.1016/S0140-6736(11)60135-9.CrossRefPubMed Schmidt MI, Duncan BB, Azevedo e Silva G, Menezes AM, Monteiro CA, Barreto SM, Chor D, Menezes PR: Chronic non-communicable diseases in Brazil: burden and current challenges. Lancet. 2011, 377: 1949-1961. 10.1016/S0140-6736(11)60135-9.CrossRefPubMed
18.
go back to reference Barbosa PJ, Lessa I, de Almeida Filho N, Magalhães LB, Araújo J: Criteria for central obesity in a Brazilian population: impact on metabolic syndrome. Arq Bras Cardiol. 2006, 87: 407-414. 10.1590/S0066-782X2006001700003.CrossRefPubMed Barbosa PJ, Lessa I, de Almeida Filho N, Magalhães LB, Araújo J: Criteria for central obesity in a Brazilian population: impact on metabolic syndrome. Arq Bras Cardiol. 2006, 87: 407-414. 10.1590/S0066-782X2006001700003.CrossRefPubMed
19.
go back to reference Marquezine GF, Oliveira CM, Pereira AC, Krieger JE, Mill JG: Metabolic syndrome determinants in an urban population from Brazil: social class and gender-specific interaction. Int J Cardiol. 2008, 129: 259-265. 10.1016/j.ijcard.2007.07.097.CrossRefPubMed Marquezine GF, Oliveira CM, Pereira AC, Krieger JE, Mill JG: Metabolic syndrome determinants in an urban population from Brazil: social class and gender-specific interaction. Int J Cardiol. 2008, 129: 259-265. 10.1016/j.ijcard.2007.07.097.CrossRefPubMed
20.
go back to reference Silventoinen K, Pankow J, Jousilahti P, Hu G, Tuomilehto J: Educational inequalities in the metabolic syndrome and coronary heart disease among middle-aged men and women. Int J Epidemiol. 2005, 34: 327-334. 10.1093/ije/dyi007.CrossRefPubMed Silventoinen K, Pankow J, Jousilahti P, Hu G, Tuomilehto J: Educational inequalities in the metabolic syndrome and coronary heart disease among middle-aged men and women. Int J Epidemiol. 2005, 34: 327-334. 10.1093/ije/dyi007.CrossRefPubMed
21.
go back to reference Loucks EB, Rehkopf DH, Thurston RC, Kawachi I: Socioeconomic disparities in metabolic syndrome differ by gender: evidence from NHANES III. Ann Epidemiol. 2007, 17: 19-26. 10.1016/j.annepidem.2006.07.002.CrossRefPubMed Loucks EB, Rehkopf DH, Thurston RC, Kawachi I: Socioeconomic disparities in metabolic syndrome differ by gender: evidence from NHANES III. Ann Epidemiol. 2007, 17: 19-26. 10.1016/j.annepidem.2006.07.002.CrossRefPubMed
23.
go back to reference Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972, 18: 499-502.PubMed Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972, 18: 499-502.PubMed
24.
go back to reference Pena SDJ, Di Pietro G, Fuchshuber-Moraes M, Genro JP, Hutz MH, Kehdy FSG, Kohlrausch F, Magno LAV, Montenegro RC, Moraes MO, Moraes MEA, Moraes MR, Ojopi EB, Perini JA, Racciopi Cl, Ribeiro-dos-Santos AKC, Rios-Santos F, Romano-Silva MA, Sortica VA, Suarez-Kurtz G: The genomic ancestry of individuals from different geographical regions of Brazil is more uniform than expected. PLoS ONE. 2011, 6: e17063-10.1371/journal.pone.0017063.PubMedCentralCrossRefPubMed Pena SDJ, Di Pietro G, Fuchshuber-Moraes M, Genro JP, Hutz MH, Kehdy FSG, Kohlrausch F, Magno LAV, Montenegro RC, Moraes MO, Moraes MEA, Moraes MR, Ojopi EB, Perini JA, Racciopi Cl, Ribeiro-dos-Santos AKC, Rios-Santos F, Romano-Silva MA, Sortica VA, Suarez-Kurtz G: The genomic ancestry of individuals from different geographical regions of Brazil is more uniform than expected. PLoS ONE. 2011, 6: e17063-10.1371/journal.pone.0017063.PubMedCentralCrossRefPubMed
25.
go back to reference Craig CL, Marshall AL, Sjöström M, Bauman AE, Booth ML, Ainsworth BE, Pratt M, Ekelund U, Yngve A, Sallis JF, Oja P: International physical activity questionnaire: 12- country reliability and validity. Med Sci Sports Exerc. 2003, 35: 1381-1395. 10.1249/01.MSS.0000078924.61453.FB.CrossRefPubMed Craig CL, Marshall AL, Sjöström M, Bauman AE, Booth ML, Ainsworth BE, Pratt M, Ekelund U, Yngve A, Sallis JF, Oja P: International physical activity questionnaire: 12- country reliability and validity. Med Sci Sports Exerc. 2003, 35: 1381-1395. 10.1249/01.MSS.0000078924.61453.FB.CrossRefPubMed
26.
go back to reference Haskell WL, Lee IM, Pate RR, Powell KE, Blair SN, Franklin BA, Macera CA, Heath GW, Thompson PD, Bauman A: Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Med Sci Sports Exerc. 2007, 39: 1423-1434. 10.1249/mss.0b013e3180616b27.CrossRefPubMed Haskell WL, Lee IM, Pate RR, Powell KE, Blair SN, Franklin BA, Macera CA, Heath GW, Thompson PD, Bauman A: Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Med Sci Sports Exerc. 2007, 39: 1423-1434. 10.1249/mss.0b013e3180616b27.CrossRefPubMed
27.
go back to reference Barros AJ, Hirakata VN: Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio. BMC Med Res Methodol. 2003, 3: 21-10.1186/1471-2288-3-21.PubMedCentralCrossRefPubMed Barros AJ, Hirakata VN: Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio. BMC Med Res Methodol. 2003, 3: 21-10.1186/1471-2288-3-21.PubMedCentralCrossRefPubMed
28.
go back to reference Monteiro CA, Conde WL, Popkin BM: Income-specific trends in obesity in Brazil: 1975–2003. Am J Public Health. 2007, 97: 1808-1812. 10.2105/AJPH.2006.099630.PubMedCentralCrossRefPubMed Monteiro CA, Conde WL, Popkin BM: Income-specific trends in obesity in Brazil: 1975–2003. Am J Public Health. 2007, 97: 1808-1812. 10.2105/AJPH.2006.099630.PubMedCentralCrossRefPubMed
29.
go back to reference Moura EC, Claro RM: Estimates of obesity trends in Brazil, 2006–2009. Int J Public Health. in press Moura EC, Claro RM: Estimates of obesity trends in Brazil, 2006–2009. Int J Public Health. in press
30.
go back to reference Ervin RB: Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index: United States, 2003–2006. Natl Health Stat Report. 2009, 13: 1-7.PubMed Ervin RB: Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index: United States, 2003–2006. Natl Health Stat Report. 2009, 13: 1-7.PubMed
31.
go back to reference Florez H, Silva E, Fernández V, Ryder E, Sulbarán T, Campos G, Calmón G, Clavel E, Castillo-Florez S, Goldberg R: Prevalence and risk factors associated with the metabolic syndrome and dyslipidemia in White, Black, Amerindian and Mixed Hispanics in Zulia State, Venezuela. Diabetes Res Clin Pract. 2005, 69: 63-77. 10.1016/j.diabres.2004.11.018.CrossRefPubMed Florez H, Silva E, Fernández V, Ryder E, Sulbarán T, Campos G, Calmón G, Clavel E, Castillo-Florez S, Goldberg R: Prevalence and risk factors associated with the metabolic syndrome and dyslipidemia in White, Black, Amerindian and Mixed Hispanics in Zulia State, Venezuela. Diabetes Res Clin Pract. 2005, 69: 63-77. 10.1016/j.diabres.2004.11.018.CrossRefPubMed
32.
go back to reference Gelaye B, Revilla L, Lopez T, Sanchez S, Williams MA: Prevalence of metabolic syndrome and its relationship with leisure time physical activity among Peruvian adults. Eur J Clin Invest. 2009, 39: 891-898. 10.1111/j.1365-2362.2009.02191.x.PubMedCentralCrossRefPubMed Gelaye B, Revilla L, Lopez T, Sanchez S, Williams MA: Prevalence of metabolic syndrome and its relationship with leisure time physical activity among Peruvian adults. Eur J Clin Invest. 2009, 39: 891-898. 10.1111/j.1365-2362.2009.02191.x.PubMedCentralCrossRefPubMed
33.
go back to reference Ramachandran A, Snehalatha C, Satyavani K, Sivasankari S, Vijay V: Metabolic syndrome in urban Asian Indian adults–a population study using modified ATP III criteria. Diabetes Res Clin Pract. 2003, 60: 199-204. 10.1016/S0168-8227(03)00060-3.CrossRefPubMed Ramachandran A, Snehalatha C, Satyavani K, Sivasankari S, Vijay V: Metabolic syndrome in urban Asian Indian adults–a population study using modified ATP III criteria. Diabetes Res Clin Pract. 2003, 60: 199-204. 10.1016/S0168-8227(03)00060-3.CrossRefPubMed
34.
go back to reference Amuna P, Zotor FB: Epidemiological and nutrition transition in developing countries: impact on human health and development. Proc Nutr Soc. 2008, 67: 82-90. 10.1017/S0029665108006058.CrossRefPubMed Amuna P, Zotor FB: Epidemiological and nutrition transition in developing countries: impact on human health and development. Proc Nutr Soc. 2008, 67: 82-90. 10.1017/S0029665108006058.CrossRefPubMed
35.
go back to reference Chow CK, Lock K, Teo K, Subramanian SV, McKee M, Yusuf S: Environmental and societal influences acting on cardiovascular risk factors and disease at a population level: a review. Int J Epidemiol. 2009, 38: 1580-1594. 10.1093/ije/dyn258.PubMedCentralCrossRefPubMed Chow CK, Lock K, Teo K, Subramanian SV, McKee M, Yusuf S: Environmental and societal influences acting on cardiovascular risk factors and disease at a population level: a review. Int J Epidemiol. 2009, 38: 1580-1594. 10.1093/ije/dyn258.PubMedCentralCrossRefPubMed
36.
go back to reference Salsberry PJ, Corwin E, Reagan PB: A complex web of risks for metabolic syndrome: race/ethnicity, economics, and gender. Am J Prev Med. 2007, 33: 114-120. 10.1016/j.amepre.2007.03.017.CrossRefPubMed Salsberry PJ, Corwin E, Reagan PB: A complex web of risks for metabolic syndrome: race/ethnicity, economics, and gender. Am J Prev Med. 2007, 33: 114-120. 10.1016/j.amepre.2007.03.017.CrossRefPubMed
37.
go back to reference Dekker JM, Girman C, Rhodes T, Nijpels G, Stehouwer CD, Bouter LM, Heine RJ: Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study. Circulation. 2005, 112: 666-673. 10.1161/CIRCULATIONAHA.104.516948.CrossRefPubMed Dekker JM, Girman C, Rhodes T, Nijpels G, Stehouwer CD, Bouter LM, Heine RJ: Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study. Circulation. 2005, 112: 666-673. 10.1161/CIRCULATIONAHA.104.516948.CrossRefPubMed
38.
go back to reference McNeill AM, Rosamond WD, Girman CJ, Golden SH, Schmidt MI, East HE, Ballantyne CM, Heiss G: The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care. 2005, 28: 385-390. 10.2337/diacare.28.2.385.CrossRefPubMed McNeill AM, Rosamond WD, Girman CJ, Golden SH, Schmidt MI, East HE, Ballantyne CM, Heiss G: The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care. 2005, 28: 385-390. 10.2337/diacare.28.2.385.CrossRefPubMed
39.
go back to reference Knuiman MW, Hung J, Divitini ML, Davis TM, Beilby JP: Utility of the metabolic syndrome and its components in the prediction of incident cardiovascular disease: a prospective cohort study. Eur J Cardiovasc Prev Rehabil. 2009, 16: 235-241. 10.1097/HJR.0b013e32832955fc.CrossRefPubMed Knuiman MW, Hung J, Divitini ML, Davis TM, Beilby JP: Utility of the metabolic syndrome and its components in the prediction of incident cardiovascular disease: a prospective cohort study. Eur J Cardiovasc Prev Rehabil. 2009, 16: 235-241. 10.1097/HJR.0b013e32832955fc.CrossRefPubMed
40.
go back to reference World Health Organization: Global health risks: mortality and burden of disease attributable to selected major risks. 2009, , Geneva World Health Organization: Global health risks: mortality and burden of disease attributable to selected major risks. 2009, , Geneva
41.
go back to reference Santos AC, Severo M, Barros H: Incidence and risk factors for the metabolic syndrome in an urban South European population. Prev Med. 2010, 50: 99-105. 10.1016/j.ypmed.2009.11.011.CrossRefPubMed Santos AC, Severo M, Barros H: Incidence and risk factors for the metabolic syndrome in an urban South European population. Prev Med. 2010, 50: 99-105. 10.1016/j.ypmed.2009.11.011.CrossRefPubMed
42.
go back to reference Despre’s JP, Lemieux I: Abdominal obesity and metabolic syndrome. Nature. 2006, 444: 881-887. 10.1038/nature05488.CrossRef Despre’s JP, Lemieux I: Abdominal obesity and metabolic syndrome. Nature. 2006, 444: 881-887. 10.1038/nature05488.CrossRef
43.
go back to reference Khunti K, Taub N, Tringham J, Jarvis J, Farooqi A, Skinner TC, Davies MJ: Screening for the metabolic syndrome using simple anthropometric measurements in south Asian and white Europeans: a population-based screening study. The Leicester Ethnic Atherosclerosis and Diabetes Risk (LEADER) Study. Prim Care Diabetes. 2010, 4: 25-32. 10.1016/j.pcd.2010.01.002.CrossRefPubMed Khunti K, Taub N, Tringham J, Jarvis J, Farooqi A, Skinner TC, Davies MJ: Screening for the metabolic syndrome using simple anthropometric measurements in south Asian and white Europeans: a population-based screening study. The Leicester Ethnic Atherosclerosis and Diabetes Risk (LEADER) Study. Prim Care Diabetes. 2010, 4: 25-32. 10.1016/j.pcd.2010.01.002.CrossRefPubMed
44.
go back to reference Alberti K, Zimmet P, Shaw J: The metabolic syndrome–a new worldwide definition. Lancet. 2005, 366: 1059-1062. 10.1016/S0140-6736(05)67402-8.CrossRefPubMed Alberti K, Zimmet P, Shaw J: The metabolic syndrome–a new worldwide definition. Lancet. 2005, 366: 1059-1062. 10.1016/S0140-6736(05)67402-8.CrossRefPubMed
45.
go back to reference Cuevas A, Alvarez V, Carrasco F: Epidemic of metabolic syndrome in Latin America. Curr Opin Endocrinol Diabetes Obes. 2011, 18: 134-138. 10.1097/MED.0b013e3283449167.CrossRefPubMed Cuevas A, Alvarez V, Carrasco F: Epidemic of metabolic syndrome in Latin America. Curr Opin Endocrinol Diabetes Obes. 2011, 18: 134-138. 10.1097/MED.0b013e3283449167.CrossRefPubMed
46.
go back to reference Alves-Silva J, da Silva Santos M, Guimarães PE, Ferreira AC, Bandelt HJ, Pena SD, Prado VF: The ancestry of Brazilian mtDNA lineages. Am J Hum Genet. 2000, 67: 444-461. 10.1086/303004.PubMedCentralCrossRefPubMed Alves-Silva J, da Silva Santos M, Guimarães PE, Ferreira AC, Bandelt HJ, Pena SD, Prado VF: The ancestry of Brazilian mtDNA lineages. Am J Hum Genet. 2000, 67: 444-461. 10.1086/303004.PubMedCentralCrossRefPubMed
47.
go back to reference Kim MH, Kim MK, Choi BY, Shin YJ: Educational disparities in the metabolic syndrome in a rapidly changing society–the case of South Korea. Int J Epidemiol. 2005, 34: 1266-1273. 10.1093/ije/dyi175.CrossRefPubMed Kim MH, Kim MK, Choi BY, Shin YJ: Educational disparities in the metabolic syndrome in a rapidly changing society–the case of South Korea. Int J Epidemiol. 2005, 34: 1266-1273. 10.1093/ije/dyi175.CrossRefPubMed
48.
go back to reference Beltrão KI, Alves JED: A reversão do hiato de gênero na educação brasileira no século XX. Cad Pesqui. 2009, 39: 125-156.CrossRef Beltrão KI, Alves JED: A reversão do hiato de gênero na educação brasileira no século XX. Cad Pesqui. 2009, 39: 125-156.CrossRef
49.
go back to reference Chichlowska KL, Rose KM, Diez-Roux AV, Golden SH, McNeill AM, Heiss G: Life course socioeconomic conditions and metabolic syndrome in adults: the Atherosclerosis Risk in Communities (ARIC) Study. Ann Epidemiol. 2009, 19: 875-883. 10.1016/j.annepidem.2009.07.094.PubMedCentralCrossRefPubMed Chichlowska KL, Rose KM, Diez-Roux AV, Golden SH, McNeill AM, Heiss G: Life course socioeconomic conditions and metabolic syndrome in adults: the Atherosclerosis Risk in Communities (ARIC) Study. Ann Epidemiol. 2009, 19: 875-883. 10.1016/j.annepidem.2009.07.094.PubMedCentralCrossRefPubMed
Metadata
Title
Metabolic syndrome in central Brazil: prevalence and correlates in the adult population
Authors
Eliane Said Dutra
Kênia MaraBaiocchi de Carvalho
Édina Miyazaki
Edgar Merchán- Hamann
Marina Kiyomi Ito
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Diabetology & Metabolic Syndrome / Issue 1/2012
Electronic ISSN: 1758-5996
DOI
https://doi.org/10.1186/1758-5996-4-20

Other articles of this Issue 1/2012

Diabetology & Metabolic Syndrome 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine